Jalan, Rajiv
European Foundation for the Study of Chronic Liver Failure · University College London
9 papers on CoChatORCID 0000-0002-7747-4015
Most cited papers
- Verified
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology
Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects
Cited by 3,286
- Verified
Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
Jalan, R., Fernandez, J., Wiest, R., Schnabl, B., Moreau, R., Angeli, P., Stadlbauer, V., Gustot, T., Bernardi, M., Canton, R., et al. (2014) · Journal of Hepatology
Liver Disease and TransplantationSepsis Diagnosis and Treatment
Cited by 906
- Verified
Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis
Fernández, J., Acevedo, J., Wiest, R., Gustot, T., Amoros, A., Deulofeu, C., Reverter, E., Martínez, J., Saliba, F., Jalan, R., et al. (2018) · Gut
Liver Disease and TransplantationSepsis Diagnosis and Treatment
Cited by 572
- Verified
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin and responds to therapeutic interventions
Kremer, A. E., van Dijk, R., Leckie, P., Schaap, F. G., Kuiper, E. M. M., Mettang, T., Reiners, K. S., Raap, U., van Buuren, H. R., van Erpecum, K. J., et al. (2012) · Hepatology
Liver Diseases and ImmunityDermatology and Skin Diseases
Cited by 291
- Verified
Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure
Mookerjee, R. P., Pavesi, M., Thomsen, K. L., Mehta, G., Macnaughtan, J., Bendtsen, F., Coenraad, M., Sperl, J., Gines, P., Moreau, R., et al. (2016) · Journal of Hepatology
Liver Disease and TransplantationSepsis Diagnosis and Treatment
Cited by 248
- Verified
Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure
Engelmann, C., Sheikh, M., Sharma, S., Kondo, T., Loeffler-Wirth, H., Zheng, Y. B., Novelli, S., Hall, A., Kerbert, A. J. C., Macnaughtan, J., et al. (2020) · Journal of Hepatology
Liver Disease and TransplantationImmune Response and Inflammation
Cited by 174
- Verified
Multimodal decoding of human liver regeneration
Matchett, K. P., Wilson-Kanamori, J. R., Portman, J. R., Kapourani, C. A., Fercoq, F., May, S., Zajdel, E., Beltran, M., Sutherland, E. F., Mackey, J. B. G., et al. (2024) · Nature
Liver physiology and pathologyDrug-Induced Hepatotoxicity and Protection
Cited by 140
- Verified
Beyond scoring: a modern interpretation of disease progression in chronic liver disease
Rosselli, M., MacNaughtan, J., Jalan, R., & Pinzani, M. (2013) · Gut
Liver Disease and TransplantationLiver Disease Diagnosis and Treatment
Cited by 96
- Verified
‘Out‐patient’ albumin dialysis for cholestatic patients with intractable pruritus
Leckie, P., Tritto, G., Mookerjee, R., Davies, N., Jones, D., & Jalan, R. (2012) · Alimentary Pharmacology & Therapeutics
Liver Disease and TransplantationLiver Diseases and Immunity
Cited by 51
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free